Breaking News

Covectra Gains GS1 EPCglobal Certification

By Kristin Brooks | February 5, 2014

AuthentiTrack serialization database and repository meet supply chain standards

Covectra, a serialization, authentication, and track and trace technology provider, has been granted GS1 EPCglobal Drug Pedigree certification. The company is now actively involved in compliance projects in the U.S., Europe, and China using this standard. Covectra will provide services for various pharmaceutical, medical device, and specialty food customers, utilizing custom serialization solutions aimed at driving supply chain security.
Covectra was awarded the GS1 EPCglobal Drug Pedigree for its AuthentiTrack serialization database and event repository after completing all the mandatory testing. EPCglobal, part of the not-for-profit supply chain standards organization GS1, is dedicated to driving the adoption of the Electronic Product Code (EPC) for supply chain excellence.
“Although the deadlines for the Drug Quality Security Act (H.R. 3204) become mandated incrementally from 2017 until 2023, many companies are recognizing that investing in technology and adhering to compliance now provides a variety of benefits. Those include improvements in supply chain efficiencies and control, as well as brand/product integrity, which all are based on serialization numbers and a system developed in accordance with GSI EPC Drug Pedigree standards,” said Steve Wood, president and chief executive officer of Covectra. “We are helping companies get ahead of the curve, while taking advantage of a variety of business benefits that can be achieved with serialization in addition to regulatory compliance. We are proud to be one of the few companies that is both EPCIS and Drug Pedigree Certified in our current markets.”

blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • CMOs: A Flexibility Alternative

    CMOs: A Flexibility Alternative

    Philip K. Burns, CRO-Consulting||January 28, 2016
    A look at how to include CMOs as an option to improve overall flexibility